Welcome to My Meds Matter

FDA Extends Comment Period on Guidance for Industry

Industry Organizations Asked for Extension

The FDA has granted a 90-day extension to the public comment period on its highly controversial draft guidance for industry

American Society of Healthcare Pharmacists logo

FDA Compounding Agreement with States May Cause Hardship for Some Patients

American Society of Healthsystem pharmacists issues warning

A proposed Food and Drug Administration (FDA) agreement with states outlining requirements and regulations for sterile compounding could negatively impact some home infusion pharmacy services - See more at: http://www.ashp.org/menu/News/NewsCapsules/Artic

2015 Survey of Veterinarians About Compounding and FDA's draft guidance

Survey of veterinarians shows that proposed FDA guidance on the use of medications that are “very important” to their practices and to patients’ medical outcome would have a large negative impact on them and their patients.

House Committee Says FDA's Compounding Policies are Overreach

Committee Demands Radical Policy Revisions

House Appropriations Committee says FDA policies go against Congressional intent

Senator David Vitter (R-LA)

Saving Access to Compounded Medications for Special Needs Patients Act

Addresses confusion over a compounding pharmacy’s “distribution” of compounded preparations

Senator David Vitter (R-LA) introduced S. 1406, the Saving Access to Compounded Medications for Special Needs Patients Act

FDA

FDA releases draft guidance on animal drug compounding

Proposed policy lays out new rules for veterinarians

The U.S. Food and Drug Administration has made good on a decade-old promise to provide updated guidance on the regulatory complexities of compounding animal drugs from bulk substances.

Urgent

Act today to save your compounded medication!

Access to compounded medications is once again at risk because of the FDA.

Your access to compounded medications is once again at risk because of the Food and Drug Administration (FDA). Help us protect your rights and add your comments to those of physicians and patients nationwide who are telling FDA to play by the rules Congre

No front page content has been created yet.